Generation Bio Reports Business Highlights & Q3 2024 Financials
06 Nov 2024 //
GLOBENEWSWIRE
Generation Bio Presents Preclinical Data On ctLNP And iqDNA
22 Oct 2024 //
GLOBENEWSWIRE
RevOpsis Awarded $1.8M Grant To Advance Ophthalmic Therapies
15 Oct 2024 //
PR NEWSWIRE
Generation Bio to Present at the 2024 Cantor Global Healthcare Conference
12 Sep 2024 //
GLOBENEWSWIRE
Generation Bio Reports Second Quarter 2024 Financial Results
07 Aug 2024 //
GLOBENEWSWIRE
Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference
06 Aug 2024 //
GLOBENEWSWIRE
Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit
14 Jun 2024 //
GLOBENEWSWIRE
Generation Bio Q1 2024 Financials, Business Highlights
13 May 2024 //
GLOBENEWSWIRE
Generation Bio Preclinical Data At ASGCT 2024
09 May 2024 //
GLOBENEWSWIRE
Regeneration Doses First Alzheimer`s Patient with Stem Cell Therapy
23 Apr 2024 //
GLOBENEWSWIRE
Generation Bio`s 5 Abstracts, Oral Presentation At ASGCT 2024
22 Apr 2024 //
GLOBENEWSWIRE
Generation Bio Reports Fourth Quarter and Full Year 2023 Financial Results
06 Mar 2024 //
GLOBENEWSWIRE
Generation Bio to Present at the 2024 TD Cowen Health Care Conference
27 Feb 2024 //
GLOBENEWSWIRE
Generation Bio Announces Strategic Reorganization to Extend Cash Runway
29 Nov 2023 //
GLOBENEWSWIRE
Generation Bio Reports Third Quarter 2023 Financial Results
09 Nov 2023 //
GLOBENEWSWIRE
Generation Bio Announces Demonstration of Highly Selective T Cell Transduction
26 Oct 2023 //
GLOBENEWSWIRE
Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference
03 Aug 2023 //
GLOBENEWSWIRE
Generation Bio Reports Second Quarter 2023 Financial Results
02 Aug 2023 //
GLOBENEWSWIRE
Generation Bio to Present at the 2023 Jefferies Healthcare Conference
31 May 2023 //
GLOBENEWSWIRE
Generation Bio Reports Business Highlights and 1Q 2023 Financial Results
10 May 2023 //
GLOBENEWSWIRE
Generation Bio to Present at the JMP Securities Life Sciences Conference
09 May 2023 //
GLOBENEWSWIRE
Generation Bio to Present at 22nd Annual Needham Virtual Healthcare Conference
11 Apr 2023 //
GLOBENEWSWIRE
Generation Bio Appoints Yalonda Howze, J.D. as Chief Legal Officer
05 Apr 2023 //
GLOBENEWSWIRE
Moderna signs licensing deal with Generation Bio in push beyond COVID
24 Mar 2023 //
REUTERS
Generation Bio to Participate in the BMO Biopharma Spotlight Series
21 Mar 2023 //
GLOBENEWSWIRE
Generation Bio to Present at the 43rd Annual Cowen Healthcare Conference
27 Feb 2023 //
GLOBENEWSWIRE
Generation Bio Reports Fourth Quarter and Full Year 2022 Financial Results
23 Feb 2023 //
GLOBENEWSWIRE
Generation Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 //
GLOBENEWSWIRE
Generation Bio Reports Business Highlights and 3Q FYR
03 Nov 2022 //
GLOBENEWSWIRE
Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit
22 Sep 2022 //
GLOBENEWSWIRE
Generation Bio Names Phillip Samayoa Chief Strategy Officer
20 Sep 2022 //
FIRSTWORLDPHARMA
Los Angeles Capital Management Acquires 47,123 Shares of Generation Bio Co.
15 Aug 2022 //
DEFENSEWORLD
Generation Bio Reports Second Quarter 2022 Financial Results
04 Aug 2022 //
GLOBENEWSWIRE
Generation Bio to Present at the 2022 Wedbush PacGrow Healthcare Conference
02 Aug 2022 //
GLOBENEWSWIRE
Generation Bio Appoints Dannielle Appelhans to Its Board of Directors
18 Jul 2022 //
GLOBENEWSWIRE
Generation Bio Announces Update to Its GMP Manufacturing Strategy
21 Jun 2022 //
GLOBENEWSWIRE
Generation Bio to Present at the 2022 Jefferies Healthcare Conference
02 Jun 2022 //
GLOBENEWSWIRE
Generation Bio Reports First Quarter 2022 Financial Results
05 May 2022 //
GLOBENEWSWIRE
Generation Bio to Participate in 21st Annual Needham Virtual Conference
05 Apr 2022 //
PRESS RELEASE
Generation Bio to Participate in 42nd Annual Cowen Health Care Conference
02 Mar 2022 //
GLOBENEWSWIRE
Generation Bio Reports Q4 and Full Year 2021 Financial Results
24 Feb 2022 //
GLOBENEWSWIRE
Generation Bio to Present at 40th Annual J.P. Morgan Healthcare Conference
10 Feb 2022 //
PRESS RELEASE
Generation Bio shares halved on hemophilia gene therapy setback
15 Dec 2021 //
FIERCEBIOTECH
Generation Bio Provides Update on Preclinical Studies for Hemophilia A Program
14 Dec 2021 //
GLOBENEWSWIRE
Generation Bio Presents Data Demonstrating First Lipid Nanoparticle
22 Oct 2021 //
GLOBENEWSWIRE
Generation Bio to Present at Jefferies Virtual Gene Therapy/Editing Summit
21 Oct 2021 //
GLOBENEWSWIRE
Generation Bio snaps up Boston area plant
15 Jul 2021 //
ENDPTS
Generation Bio Announces Pipeline Update
14 Jul 2021 //
GLOBENEWSWIRE
Generation Bio to Present at William Blair Biotech Focus Conference
08 Jul 2021 //
GLOBENEWSWIRE
Generation Bio to Present at American Society of Gene & Cell Therapy 2021
27 Apr 2021 //
GLOBENEWSWIRE
Generation Bio tees up $125M IPO to push next-gen gene therapies
26 May 2020 //
FIERCE BIOTECH